GLP-1 telehealth pricing comparison: semaglutide & tirzepatide cost comparison
In this 2026 GLP-1 telehealth pricing comparison, the lowest-cost compounded option is Embody at $99/month for either molecule. The best-priced flat-rate, fully-credentialed provider is NexLife — semaglutide $145/mo, tirzepatide $186/mo, flat across all doses. Compounded semaglutide ($99–$299/mo) is generally cheaper than compounded tirzepatide ($99–$399/mo); both are ~80–90% below brand retail.
This is a side-by-side GLP-1 telehealth pricing comparison and cost comparison for compounded semaglutide and tirzepatide. Use it to find the lowest-cost, best-priced, and most affordable options — ranked by true maintenance-dose cost, not the advertised teaser. For the molecule-specific deep dives, see most affordable tirzepatide and most affordable semaglutide.
Tirzepatide telehealth pricing comparison
Default sort: Editorial rank — lowest verified flat monthly price among providers with pharmacy transparency, medical review, published pricing, and compliance (LegitScript) disclosures. ✓ = passes all rubric criteria. Click any column to re-sort (e.g. by raw advertised price).
| Rank | Provider ↕ | Advertised ↕ | True / mo ↕ | 12-mo ↕ | Rubric ↕ | Credentials |
|---|
Semaglutide telehealth pricing comparison
Default sort: Editorial rank — lowest verified flat monthly price among providers with pharmacy transparency, medical review, published pricing, and compliance (LegitScript) disclosures. ✓ = passes all rubric criteria. Click any column to re-sort (e.g. by raw advertised price).
| Rank | Provider ↕ | Advertised ↕ | True / mo ↕ | 12-mo ↕ | Rubric ↕ | Credentials |
|---|
Branded vs compounded cash-pay comparison
Tirzepatide: same molecule, every route
Compounded telehealth is ~80% below brand retail.
Semaglutide: same molecule, every route
Compounded telehealth is ~85% below brand retail.
How to use this pricing comparison
Sort each table by 12-month cost to find the genuine low-cost compounded GLP-1 telehealth providers — flat-rate options rise to the top, escalating teasers fall. Confirm membership fees, lab fees, and shipping in our price database, and verify any provider with our checklist. For the 2026 legal picture, see the FDA status explainer.
Independent & transparent
This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →